×
About 91,985 results

ALLMedicine™ Atrial Fibrillation Center

Research & Reviews  27,648 results

Performance of the HAS-BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 3...
https://doi.org/10.1161/JAHA.121.026388
Journal of the American Heart Association; Pastori D, Marang A et. al.

Nov 30th, 2022 - Background The association between cancer types and specific bleeding events in patients with atrial fibrillation has been scarcely investigated. Also, the performance of bleeding risk scores in this high-risk subgroup of patients is unclear. We i...

Implantable loop recorders in patients with atrial fibrillation.
https://doi.org/10.1080/14779072.2022.2153673
Expert Review of Cardiovascular Therapy; Sharma AN, McIntyre WF et. al.

Nov 30th, 2022 - Implantable Loop Recorders (ILRs) provide practitioners with high-quality electrocardiographic data over an extended monitoring period. These data can guide the diagnosis and management of patients with atrial fibrillation (AF). This review summar...

Left atrial strain determinants and clinical features according to the heart failure st...
https://doi.org/10.1007/s10554-022-02669-x
The International Journal of Cardiovascular Imaging; Benfari G, Mandoli GE et. al.

Nov 30th, 2022 - Few studies analyzed left atrial (LA) peak atrial longitudinal strain (PALS) determinants, particularly across heart failure (HF) stages. We aimed to analyze the pathophysiological and clinical PALS correlates in a large multicentric prospective s...

Left atrial strain and recurrence of atrial fibrillation after thoracoscopic surgical a...
https://doi.org/10.1007/s10554-022-02645-5
The International Journal of Cardiovascular Imaging; Baalman SWE, van den Berg NWE et. al.

Nov 30th, 2022 - To assess transthoracic echocardiographic (TTE) left atrial (LA) strain parameters and their association with atrial fibrillation (AF) recurrence after thoracoscopic surgical ablation (SA) in patients in sinus rhythm (SR) or in AF at baseline. Pat...

Late gadolinium enhancement in the left ventricular wall is associated with atrial fibr...
https://doi.org/10.1007/s10554-022-02642-8
The International Journal of Cardiovascular Imaging; Castelo A, Rosa SA et. al.

Nov 30th, 2022 - Atrial fibrillation (AF) is the most common arrhythmia in patients with hypertrophic cardiomyopathy (HCM). The aim of this study was to evaluate the relation between AF and left ventricular (LV) late gadolinium enhancement (LGE). 55 patients with ...

see more →

Guidelines  53 results

Executive Summary: Perioperative Management of Antithrombotic Therapy: An American Coll...
https://doi.org/10.1016/j.chest.2022.08.004
Chest Douketis JD, Spyropoulos AC et. al.

Aug 15th, 2022 - The American College of Chest Physicians Clinical Practice Guideline on the Perioperative Management of Antithrombotic Therapy addresses 43 Patients-Interventions-Comparators-Outcomes (PICO) questions related to the perioperative management of pat...

Perioperative Management of Antithrombotic Therapy: An American College of Chest Physic...
https://doi.org/10.1016/j.chest.2022.07.025
Chest Douketis JD, Spyropoulos AC et. al.

Aug 15th, 2022 - The American College of Chest Physicians Clinical Practice Guideline on the Perioperative Management of Antithrombotic Therapy addresses 43 Patients-Interventions-Comparators-Outcomes (PICO) questions related to the perioperative management of pat...

Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review
https://pubmed.ncbi.nlm.nih.gov/35648414/
JAMA Cardiology; Bikdeli B, Zahedi Tajrishi F et. al.

Jul 1st, 2022 - Importance: Dose-reduced regimens of direct oral anticoagulants (DOACs) may be used for 2 main purposes: dose-adjusted treatment intended as full-intensity anticoagulation (eg, for stroke prevention in atrial fibrillation [AF] in patients requirin...

Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis...
https://doi.org/10.1016/j.hrthm.2022.02.022
Heart Rhythm; Sandhu RK, Seiler A et. al.

Apr 17th, 2022 - An integrated, coordinated, and patient-centered approach to atrial fibrillation (AF) care delivery may improve outcomes and reduce cost. The purpose of this study was to gain a better understanding from key stakeholder groups on current practices...

Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Sta...
https://doi.org/10.1001/jama.2021.23732
JAMA , Davidson KW et. al.

Jan 26th, 2022 - Atrial fibrillation (AF) is the most common cardiac arrhythmia. The prevalence of AF increases with age, from less than 0.2% in adults younger than 55 years to about 10% in those 85 years or older, with a higher prevalence in men than in women. It...

see more →

Drugs  724 results see all →

Clinicaltrials.gov  3,027 results

Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation
https://clinicaltrials.gov/ct2/show/NCT03729830

Oct 14th, 2022 - STUDY OBJECTIVE(S) -- To obtain data for the Rhythmia™ Mapping System in conjunction with Boston Scientific Open-Irrigated (OI) Catheters for ablation of Paroxysmal Atrial Fibrillation (PAF) according to current international and local guidelines....

Electrical Coupling Information From The RHYTHMIA HDx Mapping System and DIRECTSENSE Technology In The Treatment of Paroxysmal Atrial Fibrillation (LOCALIZE CF)
https://clinicaltrials.gov/ct2/show/NCT04740801

Oct 14th, 2022 - The objective of this study is to evaluate whether local impedance (DIRECTSENSE™) drop on the INTELLANAV STABLEPOINT™ ablation catheter is associated with late pulmonary vein (PV) reconnections and durable conduction block in patients undergoing d...

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France
https://clinicaltrials.gov/ct2/show/NCT05038228

Oct 14th, 2022 - This study is a retrospective analysis of observational cohorts using data from prospectively collected administrative/claims data to investigate treatment patterns, and safety and effectiveness outcomes in patients with NVAF with high risk of gas...

MultiPulse Therapy (MPT) for AF
https://clinicaltrials.gov/ct2/show/NCT04206917

Oct 14th, 2022 - A prospective non-randomized feasibility study involving acute testing of MPT in subjects with paroxysmal and persistent AF during clinically indicated atrial fibrillation catheter ablation procedure. Subjects will be split into 2 cohorts dependin...

Prevalence of Hazardous Alcohol Use in a Population With Hypertension in Primary Care
https://clinicaltrials.gov/ct2/show/NCT05580549

Oct 14th, 2022 - Hypertension, tobacco smoking, and alcohol use are the three leading risk factors for global disease burden. Treatment of hypertensive disease is important for the prevention of atherosclerotic disease, atrial fibrillation, heart failure, stroke, ...

see more →

News  5,274 results

Alzheimer's Drug Slows Decline, Trial Data Show
https://www.medpagetoday.com/neurology/alzheimersdisease/101972

Nov 30th, 2022 - Treatment with the investigational anti-amyloid agent lecanemab led to modestly less decline on cognitive and functional measures in the phase III CLARITY AD trial of early Alzheimer's disease, but was associated with adverse events. From a baseli...

AFib Risk Rises as A1c Increases
https://www.medscape.com/viewarticle/984714

Nov 29th, 2022 - Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed. Key Takeaways Adults not receiving glucose-lowering drugs showed a stepwise, increasing risk of developing atrial fibrill...

Factor Xa Inhibitors Tied to Interstitial Lung Disease in AF
https://www.medscape.com/viewarticle/984544

Nov 23rd, 2022 - In patients with nonvalvular atrial fibrillation (NVAF), treatment with factor Xa (FXa) inhibitors was associated with a greater risk of interstitial lung disease (ILD) than other oral anticoagulants (OACs), a medical records analysis shows. Emerg...

Illegal Diet Supplements for CVD; Lung Disease in OAC Users; Myocarditis Mechanism
https://www.medpagetoday.com/cardiology/prevention/101876

Nov 22nd, 2022 - FDA sent warnings to seven companies selling dietary supplements with unlawful claims of treating or preventing cardiovascular disease. A study from Taiwan showed that there was an increased risk of interstitial lung disease in people using oral a...

Long-Term Treatment With Ibrutinib Is Possible in Newly Diagnosed CLL/SLL
https://www.onclive.com/view/long-term-treatment-with-ibrutinib-is-possible-in-newly-diagnosed-cll-sll

Nov 21st, 2022 - Treatment with ibrutinib (Imbruvica) for at least 5 years showed favorable complete response (CR) rates and tolerability in patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who were randomized to receive the BTK in...

see more →

Patient Education  68 results see all →